Weiyel Pneumonia Pathogen Comprehensive Detection Standard Material Series

Published：2025-11-26 10:13 Editor：Weiyel

Weiyel launches a comprehensive series of reference materials for pneumonia pathogen detection, fully covering the identification, typing, and drug resistance analysis of Mycoplasma pneumoniae and Chlamydia pneumoniae, providing a complete and reliable quality control system for molecular diagnostics.

This series encompasses three main modules to help laboratories meet all testing challenges:

1. Precise Identification, Clarifying the Pathogen

* Mycoplasma pneumoniae P1 gene pseudovirus reference material: Enables specific identification and typing of Mycoplasma pneumoniae.

* Chlamydia pneumoniae 16S rRNA gene pseudovirus reference material: Accurately identifies another common atypical pathogen—Chlamydia pneumoniae.

2. Drug Resistance Typing, Guiding Medication

* Mycoplasma pneumoniae 23S rRNA gene (wild-type) pseudovirus reference material: Provides a baseline for drug sensitivity.

* Five Drug Resistance Mutation Typing Reference Materials: Covers four key sites—A2063G, A2064G, A2067G, and C2617G—for precise detection of macrolide drug resistance and clear differentiation between wild-type and mutant types.

3. Quantitative Mutation Analysis: Gaining Early Insight

Four Mutation Abundance Standards: Designed specifically for A2063G, A2064G, A2067G, and C2617G sites, these standards simulate clinical mixed infections (coexistence of wild-type and mutant strains), accurately assessing the sensitivity of detection methods to low-frequency mutations and providing quantitative evidence for clinical assessment of drug resistance.

Series Advantages:
Comprehensive Coverage: Meets the entire quality control process from pathogen identification to drug resistance analysis.

Safe and Reliable: The pseudovirus design is non-infectious yet perfectly simulates the real testing environment.

Precise Quantification: Unique abundance standards propel drug resistance detection from qualitative to quantitative levels.

Choosing Weiyel means choosing completeness and precision. This series is ideal for developing, validating, and quality-controlling molecular diagnostic kits for respiratory pathogens, helping to improve the standardization and precision of pneumonia diagnosis and treatment.

Product Number	Product Name	Specifications	Standard Value
BWM300014	Mycoplasma pneumoniae P1 gene pseudovirus reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300015	Mycoplasma pneumoniae 23S rRNA gene (wild type) pseudovirus reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300016	Mycoplasma pneumoniae 23S rRNA gene mutation (A2063G) pseudovirus reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300017	Mycoplasma pneumoniae 23S rRNA gene mutation (A2064G) pseudovirus reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300018	Mycoplasma pneumoniae 23S rRNA gene mutation (C2617G) pseudovirus standard material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300019	Chlamydia pneumoniae 16S rRNA gene pseudovirus reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300020	Mycoplasma pneumoniae 23S rRNA gene mutation (A2067G) pseudovirus reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300021	Mycoplasma pneumoniae 23S rRNA (A2063G) gene mutation abundant in antiviral reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300022	Mycoplasma pneumoniae 23S rRNA (A2064G) gene mutation abundant in antiviral reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL
BWM300023	Mycoplasma pneumoniae 23S rRNA (A2067G) gene mutation abundant in antiviral reference material	230μL*5Tube	1×10^4 - 1×10^6 IU/mL

Previous：Congratulations to Weiyel on Successful Completion of 2025 ANAB ISO/IEC 17034 Surveillance Audit Next：Weiyel Launches Plasmid DNA Reference Material Series for Antibiotic Resistance Gene Detection